1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
EPIOMIC EPIDEMIOLOGY SERIES: MIGRAINE FORECAST IN 12 MAJOR MARKETS 2018–2028

EPIOMIC EPIDEMIOLOGY SERIES: MIGRAINE FORECAST IN 12 MAJOR MARKETS 2018–2028

  • April 2018
  • 54 pages
  • ID: 5377411
  • Format: PDF
  • By Black Swan Analysis Ltd

Summary

Table of Contents

Search Inside

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Migraine in 12 Major Markets
Migraine is a common neurological disorder involving repeated headaches and associated phenomena. It is a leading cause of disability throughout the world. It has a multifactorial background (genetic, environmental, metabolic, hormonal, pharmacological) and triggers that vary between patients. However, it presents a common pattern of occurrence, with peak incidence in adolescence and peak prevalence in middle age. Recent research advances have helped to better determine the brain structures involved in migraine and observe physiological changes in patients with the disorder. These advances are the basis for studies of novel therapeutics and prophylactic approaches.
This report provides the current prevalent population for migraine across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Japan, China, India, Brazil) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several features of migraine patients, as well as the main symptoms of the disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main co-morbidities of migraine include:
•Hypertension (depending on the study)
•Mood disorders (anxiety, depression)
•Obesity
•Abdominal pain
•Emesis
•Cyclic vomiting syndrome (in children)
•Multiple sclerosis
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world-class sources that deliver the most up-to-date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
•Ability to quantify patient populations in global migraine market to target the development of future products, pricing strategies and launch plans.
•Further insight into the prevalence of the subdivided types of migraine and identification of patient segments with high potential.
•Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
•Better understanding of the impact of specific symptoms on the prevalent population of migraine patients.
•Identification of migraine patient sub-populations that require treatment.
•Better understanding of the specific markets that have the largest number of migraine patients.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H2 2019

Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H2 2019

  • $ 2000
  • August 2019

Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H2 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Cluster Headache Syndrome - Pipeline ...

Fibromyalgia - Pipeline Review, H2 2019

Fibromyalgia - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Fibromyalgia - Pipeline Review, H2 2019SummaryPharmaceutical and Healthcare disease pipeline guide Fibromyalgia - Pipeline Review, H2 2019, provides an overview of the Fibromyalgia (Central Nervous System) ...

Urinary Incontinence - Pipeline Review, H2 2019

Urinary Incontinence - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Urinary Incontinence - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2019, provides an overview of the Urinary ...

Analgesics in Norway $ 990 October 2019

Analgesics in Western Europe $ 1325 October 2019


Download Unlimited Documents from Trusted Public Sources

OTC Industry Analysis - Forecast

  • October 2019
    13 pages
  • OTC  

    Antifungal  

  • United States  

    North America  

    Europe  

View report >

Global Pain Relief Forecast

  • October 2019
    4 pages
  • Pain Relief  

    Therapy  

  • World  

    United States  

View report >

Global OTC Markets

  • October 2019
    36 pages
  • OTC  

    Pharmacy  

  • World  

    Europe  

View report >

Pain Relief Supply 3 months ago

Global OTC Markets 4 months ago

OTC Industry in the US 4 months ago


ref:plp2018

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on